Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022;E111-119. doi: 10.1001/amajethics.2022.111. Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145. Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396. Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483. Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495. Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518. Health Law May 2022 ¿La regulación de suplementos dietéticos como alimentos promueve la seguridad pública en un mundo de influentes en redes sociales? Joshua Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences. AMA J Ethics. 2022;E396-401. doi: 10.1001/amajethics.2022.396. Pagination First page « First Previous page ‹ Previous … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Next page Next › Last page Last »
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022;E111-119. doi: 10.1001/amajethics.2022.111.
Policy Forum Feb 2022 Por qué los enfoques no carcelarios basados en la atención para las personas detenidas con enfermedades mentales son clave para volver a confiar o no en los profesionales o la autoridad estatal Frederic G. Reamer, PhD AMA J Ethics. 2022;E145-149. doi: 10.1001/amajethics.2022.145.
Health Law May 2022 Does Regulating Dietary Supplements as Food in a World of Social Media Influencers Promote Public Safety? Joshua J. Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences. AMA J Ethics. 2022;24(5):E396-401. doi: 10.1001/amajethics.2022.396.
Case and Commentary Jun 2022 How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants? Christopher W. Reynolds and Camilo Sánchez Meertens, MPP Clinicians in postconflict health care settings can be tasked with caring for patients who were enemies. AMA J Ethics. 2022;24(6):E483-488. doi: 10.1001/amajethics.2022.483.
Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495.
Original Research Jun 2022 Why We Need Stricter Oversight of Research Involving Human Subjects Affected by Conflict Anushka Ataullahjan, PhD, Samantha Lo, MSc, Mohammad Haaris Aziz, MBBCh, Nadia Amin Somani, and Zulfiqar A. Bhutta, PhD, MBBS Systematic analysis of extant research ethics guidance is needed for conflict-affected countries and UN agencies. AMA J Ethics. 2022;24(6):E518-529. doi: 10.1001/amajethics.2022.518.
Health Law May 2022 ¿La regulación de suplementos dietéticos como alimentos promueve la seguridad pública en un mundo de influentes en redes sociales? Joshua Klein and Scott J. Schweikart, JD, MBE Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary can have clinical and public health consequences. AMA J Ethics. 2022;E396-401. doi: 10.1001/amajethics.2022.396.